Likewise, in silico analysis using the Oncomine Cancer Microarray Database revealed the significant upregulation of NAMPT expression levels in CRC tissues compared with those in nontumorous samples in different patient-derived datasets [29–31] (Fig. 1d). The gene discussed is NAMPT; the disease is cancer.